Akers Biosciences Inc (AKR)

 

Latest News

Issue of Equity

RNS Number: 0634C Akers Biosciences, Inc. 16 January 2018 January 16, 2018 Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces that, pursuant to the Public Offering announced on December 19, 2017, the Company has receive...

Update RE Admission of Shares

RNS Number: 8088B Akers Biosciences, Inc. 15 January 2018 January 15, 2018 Akers Biosciences, Inc. Update Re: Admission of Shares Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, provides an update on the admission of shares previously announced in the Issue of Equity...

Akers Biosciences in equity issue

Akers Biosciences has issued 9,366,668 common shares after receiving applications for the conversion of 1,405 shares of serie...

Issue of Equity

RNS Number: 6720B Akers Biosciences, Inc. 12 January 2018 January 12, 2018 Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces that, pursuant to the Public Offering announced on December 19, 2017, the Company has receiv...

All News

DateHeadlineSource
16-01-18Issue of EquityRNS
15-01-18Update RE Admission of SharesRNS
12-01-18Akers Biosciences in equity issue StockMarketWire
12-01-18Issue of EquityRNS
05-01-18Issue of EquityRNS
04-01-18Holdings in CompanyRNS
27-12-17Issue of EquityRNS
22-12-17Akers Bio public offering closes StockMarketWire
22-12-17Closing of Public OfferingRNS
19-12-17Issue of EquityRNS
18-12-17Form S-1 Registration Statement - AmendmentRNS
15-12-17Form S-1 Registration Statement - AmendmentRNS
14-12-17Form S-1 Registration Statement - AmendmentRNS
11-12-17Form S-1 Registration Statement - AmendmentRNS
08-12-17Further IP Protection for Akers Wellness LineRNS
01-12-17Form 8K FilingRNS
27-11-17Form S-1 Registration StatementRNS
15-11-17Akers Bio revenues up 10%StockMarketWire
15-11-173rd Quarter ResultsRNS
14-11-17Akers Bio sees new UK channel for breathalyzerStockMarketWire
14-11-17New UK Channel for Rapid Alcohol BreathalyzerRNS
13-11-17Akers schedules results announcementStockMarketWire
13-11-17Notice of ResultsRNS
08-11-17Akers issues sharesStockMarketWire
08-11-17Issue of EquityRNS
20-10-17PDMR Shareholding and Issue of EquityRNS
19-10-17Director/PDMR ShareholdingRNS
13-10-17Warrant Amendment and ExerciseRNS
07-09-17Appointment of U.S. VP of Sales & DistributionRNS
15-08-17Akers Bio revenues up 10%StockMarketWire
15-08-17Half-year ReportRNS
11-08-17Akers Bio in equity issue StockMarketWire
11-08-17Issue of EquityRNS
08-08-17Akers Bio resolutions passed at AGMStockMarketWire
08-08-17Result of AGMRNS
04-08-17Akers Bio second quarter sales jumpStockMarketWire
03-08-17Trading Update and Notice of Q2 ResultsRNS
20-07-17Holding(s) in CompanyRNS
14-07-17Board changes proposed at Akers Biosciences' AGMStockMarketWire
14-07-17Notice of AGM & Directorate ChangesRNS

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account